Amber Road Inc (AMBR) Jumps 5.41% on February 19

Equities Staff |

Amber Road Inc (AMBR) was among the biggest gainers on the Russell 2000 for Friday February 19 as the stock popped 5.41% to $4.39, representing a gain of $0.225 per share. Some 333,298 shares traded hands on 1,358 trades, compared with an average daily volume of 121,604 shares out of a total float of 26.26 million. The stock opened at $4.15 and traded with an intraday range of $4.82 to $4.09.

After today's gains, Amber Road Inc reached a market cap of $115.13 million. Amber Road Inc has had a trading range between $9.69 and $3.42 over the last year, and it had a 50-day SMA of $4.53 and a 200-day SMA of $5.32.

Amber Road Inc is a provider of cloud-based trade management (GTM) solutions. It automates import and export processes to enable goods to flow across international borders in the efficient way.

Amber Road Inc is based out of East Rutherford, NJ and has some 547 employees. Its CEO is James W. Preuninger.

For a complete fundamental analysis analysis of Amber Road Inc, check out Equities.com’s Stock Valuation Analysis report for AMBR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…